Obsidian Therapeutics, Inc.
OBX
$17.77
-$1.15-6.08%
NASDAQ
| 03/31/2026 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.76M | 168.27M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 4.58M | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | 700.00K | -- | |||
| Total Current Assets | 64.04M | -- | |||
|
|
|||||
| Total Current Assets | 64.04M | -- | |||
| Net Property, Plant & Equipment | 5.09M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 1.00M | -- | |||
| Total Assets | 70.14M | -- | |||
|
|
|||||
| Total Accounts Payable | 738.00K | -- | |||
| Total Accrued Expenses | 10.38M | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 2.53M | -- | |||
| Total Finance Division Other Current Liabilities | 1.58M | -- | |||
| Total Other Current Liabilities | 1.58M | -- | |||
| Total Current Liabilities | 15.23M | -- | |||
|
|
|||||
| Total Current Liabilities | 15.23M | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 1.07M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | 3.00K | -- | |||
| Total Liabilities | 16.31M | -- | |||
|
|
|||||
| Common Stock & APIC | 39.38M | -- | |||
| Retained Earnings | -315.57M | -- | |||
| Treasury Stock & Other | -5.00K | -- | |||
| Total Common Equity | -276.20M | -174.43M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 330.03M | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 330.03M | 338.03M | |||
|
|
|||||
| Total Common Equity | -276.20M | -174.43M | |||
| Total Preferred Equity | 330.03M | 338.03M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 53.83M | 163.60M | |||
|
|
|||||